IBDEI150 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20064,1,5,0)
 ;;=5^Insomnia
 ;;^UTILITY(U,$J,358.3,20064,2)
 ;;=^332924
 ;;^UTILITY(U,$J,358.3,20065,0)
 ;;=600.01^^105^1241^15
 ;;^UTILITY(U,$J,358.3,20065,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20065,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,20065,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,20065,2)
 ;;=^334256
 ;;^UTILITY(U,$J,358.3,20066,0)
 ;;=346.90^^105^1241^54
 ;;^UTILITY(U,$J,358.3,20066,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20066,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,20066,1,5,0)
 ;;=5^Migraine
 ;;^UTILITY(U,$J,358.3,20066,2)
 ;;=^336879
 ;;^UTILITY(U,$J,358.3,20067,0)
 ;;=723.1^^105^1241^57
 ;;^UTILITY(U,$J,358.3,20067,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20067,1,4,0)
 ;;=4^723.1
 ;;^UTILITY(U,$J,358.3,20067,1,5,0)
 ;;=5^Neck Pain
 ;;^UTILITY(U,$J,358.3,20067,2)
 ;;=^21917
 ;;^UTILITY(U,$J,358.3,20068,0)
 ;;=607.84^^105^1241^53
 ;;^UTILITY(U,$J,358.3,20068,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20068,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,20068,1,5,0)
 ;;=5^Male Erectile Disorder
 ;;^UTILITY(U,$J,358.3,20068,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,20069,0)
 ;;=173.99^^105^1241^83
 ;;^UTILITY(U,$J,358.3,20069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20069,1,4,0)
 ;;=4^173.99
 ;;^UTILITY(U,$J,358.3,20069,1,5,0)
 ;;=5^Skin Cancer NOS
 ;;^UTILITY(U,$J,358.3,20069,2)
 ;;=^340493
 ;;^UTILITY(U,$J,358.3,20070,0)
 ;;=278.01^^105^1241^55
 ;;^UTILITY(U,$J,358.3,20070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20070,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,20070,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,20070,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,20071,0)
 ;;=585.6^^105^1241^34
 ;;^UTILITY(U,$J,358.3,20071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20071,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,20071,1,5,0)
 ;;=5^End Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,20071,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,20072,0)
 ;;=482.1^^105^1241^81
 ;;^UTILITY(U,$J,358.3,20072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20072,1,4,0)
 ;;=4^482.1
 ;;^UTILITY(U,$J,358.3,20072,1,5,0)
 ;;=5^Pseudomonal Pneumonia
 ;;^UTILITY(U,$J,358.3,20072,2)
 ;;=^269932
 ;;^UTILITY(U,$J,358.3,20073,0)
 ;;=482.2^^105^1241^37
 ;;^UTILITY(U,$J,358.3,20073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20073,1,4,0)
 ;;=4^482.2
 ;;^UTILITY(U,$J,358.3,20073,1,5,0)
 ;;=5^H. Influenzae Pneumonia
 ;;^UTILITY(U,$J,358.3,20073,2)
 ;;=^269933
 ;;^UTILITY(U,$J,358.3,20074,0)
 ;;=482.84^^105^1241^50
 ;;^UTILITY(U,$J,358.3,20074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20074,1,4,0)
 ;;=4^482.84
 ;;^UTILITY(U,$J,358.3,20074,1,5,0)
 ;;=5^Legionnaires' Disease
 ;;^UTILITY(U,$J,358.3,20074,2)
 ;;=^68817
 ;;^UTILITY(U,$J,358.3,20075,0)
 ;;=482.9^^105^1241^17
 ;;^UTILITY(U,$J,358.3,20075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20075,1,4,0)
 ;;=4^482.9
 ;;^UTILITY(U,$J,358.3,20075,1,5,0)
 ;;=5^Bacterial Pneumonia NOS
 ;;^UTILITY(U,$J,358.3,20075,2)
 ;;=^12347
 ;;^UTILITY(U,$J,358.3,20076,0)
 ;;=430.^^105^1241^88
 ;;^UTILITY(U,$J,358.3,20076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20076,1,4,0)
 ;;=4^430.
 ;;^UTILITY(U,$J,358.3,20076,1,5,0)
 ;;=5^Subarachnoid Hemorrhage
 ;;^UTILITY(U,$J,358.3,20076,2)
 ;;=^114989
 ;;^UTILITY(U,$J,358.3,20077,0)
 ;;=434.91^^105^1241^24
 ;;^UTILITY(U,$J,358.3,20077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20077,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,20077,1,5,0)
 ;;=5^Crb Art Occl,Unspec w/ CRB Inf
 ;;^UTILITY(U,$J,358.3,20077,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,20078,0)
 ;;=431.^^105^1241^47
 ;;^UTILITY(U,$J,358.3,20078,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI150
